Rucay P - Search Results

1

In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.

Sadeg N, Pham-Huy C, Rucay P, Righenzi S, Halle-Pannenko O, Claude JR, Bismuth H, Duc HT. Sadeg N, et al. Among authors: rucay p. Immunopharmacol Immunotoxicol. 1993 Mar-Jun;15(2-3):163-77. doi: 10.3109/08923979309025992. Immunopharmacol Immunotoxicol. 1993. PMID: 8349948

2

Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506.

Saada V, Pham-Huy C, Voisin J, Righenzi S, Rucay P, Claude JR, Duc HT. Saada V, et al. Among authors: rucay p. Int J Immunopharmacol. 1996 Jan;18(1):79-87. doi: 10.1016/0192-0561(95)00108-5. Int J Immunopharmacol. 1996. PMID: 8732436

3

Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line.

Massicot F, Martin C, Dutertre-Catella H, Ellouk-Achard S, Pham-Huy C, Thevenin M, Rucay P, Warnet JM, Claude JR. Massicot F, et al. Among authors: rucay p. Arch Toxicol. 1997;71(8):529-31. doi: 10.1007/s002040050423. Arch Toxicol. 1997. PMID: 9248632

4

Differential modulation of the in vitro lymphocyte activation pathways by soluble and solubilized placental substances.

Duc HT, Nakagawa S, Rucay P, Righenzi S, Voisin GA. Duc HT, et al. Among authors: rucay p. Am J Reprod Immunol. 1990 Nov;24(3):73-9. doi: 10.1111/j.1600-0897.1990.tb01042.x. Am J Reprod Immunol. 1990. PMID: 2076185

5

Monoclonal antibodies directed against T cell epitopes presented by class I MHC antigens.

Duc HT, Rucay P, Righenzi S, Halle-Pannenko O, Kourilsky P. Duc HT, et al. Among authors: rucay p. Int Immunol. 1993 Apr;5(4):427-31. doi: 10.1093/intimm/5.4.427. Int Immunol. 1993. PMID: 7684252

6

FK 506 rescue therapy for refractory acute rejection in five liver recipients.

Rucay P, Samuel D, Gillet D, Bismuth H. Rucay P, et al. Transplant Proc. 1991 Dec;23(6):3000-1. Transplant Proc. 1991. PMID: 1721340 No abstract available.

7

Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients.

Rudant E, Bezie Y, Bonhomme-Faivre L, Manuel N, Rucay P, Fredj G, Bismuth H. Rudant E, et al. Among authors: rucay p. J Clin Pharm Ther. 1997 Apr;22(2):135-40. doi: 10.1111/j.1365-2710.1997.tb00007.x. J Clin Pharm Ther. 1997. PMID: 9373812

8

[Isolation and characterization of monoclonal antibody directed against antigenic peptide presented by class I histocompatibility molecule].

Duc HT, Rucay P, Righenzi S, Halle-Pannenko O, Kourilsky P. Duc HT, et al. Among authors: rucay p. C R Acad Sci III. 1992;314(10):437-42. C R Acad Sci III. 1992. PMID: 1381657 French.

9

FK 506 as treatment of late acute rejection in liver transplant patients.

Rucay P, Samuel D, Farges O, Reynes M, Bismuth H. Rucay P, et al. Transplant Proc. 1995 Feb;27(1):1105-6. Transplant Proc. 1995. PMID: 7533354 Clinical Trial. No abstract available.

10

Serum uric acid and liver transplantation.

Taillandier J, Alemanni M, Lioté F, Rucay P, Samuel D, Bismuth H. Taillandier J, et al. Among authors: rucay p. Transplant Proc. 1995 Jun;27(3):2189-90. Transplant Proc. 1995. PMID: 7792928 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters